Medtronic’s Q2 Revenue Hits $4.095 Billion

Medtronic Inc. (NYSE:MDT), a company that manufactures heart-rhythm devices, announced its financial results for the period ended October 26, 2012, the second quarter of its 2013 fiscal year, commenting that its revenue was $4.095 billion, an increase of 5 percent on a constant currency basis.

As quoted in the press release:

Second quarter international revenue of $1.806 billion increased 8 percent on a constant currency basis or 1 percent as reported.  International sales accounted for 44 percent of Medtronic’s worldwide revenue in the quarter.  Emerging market revenue of $464 million increased 18 percent on a constant currency basis or 14 percent as reported and represented 11 percent of Company revenue.

Click here to read the full Medtronic Inc. (NYSE:MDT) press release.